TY - JOUR
T1 - Loading of curcumin into macrophages using lipid-based nanoparticles
AU - Sou, Keitaro
AU - Inenaga, Shunsuke
AU - Takeoka, Shinji
AU - Tsuchida, Eishun
N1 - Funding Information:
This work was partly supported by the Japanese Ministry of Education, Culture, Sports, Science and Technology, through a Grant-in-Aid for Scientific Research (B) (17300162, 2005). The authors gratefully acknowledge Dr. William T. Phillips and Dr. Beth Goins (UTHSCSA) for suggestion and discussion for this research.
PY - 2008/3/20
Y1 - 2008/3/20
N2 - Curcumin (1,7-bis(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione, Cm) is a natural compound which possesses antioxidant, anti-inflammatory and anti-tumor ability. Here, phospholipid vesicles or lipid-nanospheres embedding Cm (CmVe or CmLn) were formulated to deliver Cm into tissue macrophages through intravenous injection. Cm could be solubilized in hydrophobic regions of these particles to form nanoparticle dispersions, and these formulations showed ability to scavenge reactive oxygen species as antioxidants in dispersions. At 6 h after intravenous injection in rats via the tail vein (2 mg Cm/kg bw), confocal microscopic observations of tissue sections showed that Cm was massively distributed in cells assumed as macrophages into the bone marrow and spleen. Taken together, these results indicate that the lipid-based nanoparticulates provide improved intravenous delivery of Cm to tissues macrophages, specifically bone marrow and splenic macrophages in present formulation, which has therapeutic potential as an antioxidant and anti-inflammatory.
AB - Curcumin (1,7-bis(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione, Cm) is a natural compound which possesses antioxidant, anti-inflammatory and anti-tumor ability. Here, phospholipid vesicles or lipid-nanospheres embedding Cm (CmVe or CmLn) were formulated to deliver Cm into tissue macrophages through intravenous injection. Cm could be solubilized in hydrophobic regions of these particles to form nanoparticle dispersions, and these formulations showed ability to scavenge reactive oxygen species as antioxidants in dispersions. At 6 h after intravenous injection in rats via the tail vein (2 mg Cm/kg bw), confocal microscopic observations of tissue sections showed that Cm was massively distributed in cells assumed as macrophages into the bone marrow and spleen. Taken together, these results indicate that the lipid-based nanoparticulates provide improved intravenous delivery of Cm to tissues macrophages, specifically bone marrow and splenic macrophages in present formulation, which has therapeutic potential as an antioxidant and anti-inflammatory.
KW - Antioxidant
KW - Bone marrow
KW - Drug delivery
KW - Liposomes
KW - Macrophage
KW - Nanoparticles
UR - http://www.scopus.com/inward/record.url?scp=39549102649&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=39549102649&partnerID=8YFLogxK
U2 - 10.1016/j.ijpharm.2007.10.033
DO - 10.1016/j.ijpharm.2007.10.033
M3 - Article
C2 - 18063327
AN - SCOPUS:39549102649
SN - 0378-5173
VL - 352
SP - 287
EP - 293
JO - International Journal of Pharmaceutics
JF - International Journal of Pharmaceutics
IS - 1-2
ER -